Evidence map›Paper›PMID 27925796›Full record

ArticleAmerican journal of respiratory and critical care medicine2017

A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from U-BIOPRED Cohorts.

Jeannette Bigler, Michael Boedigheimer, James P R Schofield, Paul J Skipp, Julie Corfield, Anthony Rowe, Ana R Sousa, Martin Timour, Lori Twehues, Xuguang Hu and 11 more

Registry-linked trialOpen access · greenAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01982162 (Protocol for the European Multi-Centre Study Understanding Severe Asthma Longitudinal Assessment of Children With Severe Asthma and Severe Pre-school Wheeze), which is not on this map. Cited by 114 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 1 pooled it
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01982162 completednot on this map

Protocol for the European Multi-Centre Study Understanding Severe Asthma Longitudinal Assessment of Children With Severe Asthma and Severe Pre-school Wheeze

TypeobservationalSponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Ran2011 to 2014Enrolled300ConditionsAsthma
3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 1 synthesis or guideline pooled it, 183 citations in OpenAlex.

  1. Shared DNA methylation signatures in childhood allergy: The MeDALL study.The Journal of allergy and clinical immunology · 2021
    Pooled it
  2. Dexamethasone-Induced FKBP51 Expression in CD4Frontiers in immunology · 2021
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Distinct blood transcriptomic profiling underlying asthma establishment and exacerbation.The journal of allergy and clinical immunology. Global · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Distinct single-cell transcriptional profile in CD4+ T-lymphocytes among obese children with asthma.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  17. Review
  18. Copy Number Variation in Asthma: An Integrative Review.Clinical reviews in allergy & immunology · 2025
    Review
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 5 countries.

Jeannette Bigler1 Amgen Inc., Seattle, Washington.
Michael Boedigheimer2 Amgen Inc., Thousand Oaks, California.
James P R Schofield3 Centre for Biological Sciences, Southampton University, Southampton, United Kingdom.
Paul J Skipp3 Centre for Biological Sciences, Southampton University, Southampton, United Kingdom.
Julie Corfield4 AstraZeneca R&D, Molndal, Sweden.
Anthony Rowe6 Janssen Research and Development, High Wycombe, United Kingdom.
Ana R Sousa7 Respiratory Therapeutic Unit, GSK, Stockley Park, United Kingdom.
Martin Timour1 Amgen Inc., Seattle, Washington.
Lori Twehues2 Amgen Inc., Thousand Oaks, California.
Xuguang Hu8 Amgen Inc., South San Francisco, California.
Graham Roberts9 Respiratory Biomedical Research Unit, Faculty of Medicine, University Hospital Southampton, Southampton, United Kingdom.
Andrew A Welcher2 Amgen Inc., Thousand Oaks, California.
Wen Yu1 Amgen Inc., Seattle, Washington.
Diane Lefaudeux10 European Institute for Systems Biology and Medicine, Centre National de la Recherche Scientifique, Lyon, France.
Bertrand De Meulder10 European Institute for Systems Biology and Medicine, Centre National de la Recherche Scientifique, Lyon, France.
Charles Auffray10 European Institute for Systems Biology and Medicine, Centre National de la Recherche Scientifique, Lyon, France.
Kian F Chung11 National Heart & Lung Institute, Imperial College & Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, United Kingdom; and.
Ian M Adcock11 National Heart & Lung Institute, Imperial College & Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, United Kingdom; and.
Peter J Sterk12 Department of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
Ratko Djukanović9 Respiratory Biomedical Research Unit, Faculty of Medicine, University Hospital Southampton, Southampton, United Kingdom.
U-BIOPRED Study Group ‖
Amgen (United States) · USCentre National pour la Recherche Scientifique et Technique (CNRST) · MANIHR Southampton Biomedical Research Centre · GBRoyal Brompton & Harefield NHS Foundation Trust · GBUniversity Hospital Southampton NHS Foundation Trust · GBArete (United Kingdom) · GBJanssen (United Kingdom) · GBUniversity of Amsterdam · NL

Funding

Medical Research Council G1000758Medical Research Council G1001367
6 · The paper itself

Abstract

rationaleStratification of asthma at the molecular level, especially using accessible biospecimens, could greatly enable patient selection for targeted therapy.

objectivesTo determine the value of blood analysis to identify transcriptional differences between clinically defined asthma and nonasthma groups, identify potential patient subgroups based on gene expression, and explore biological pathways associated with identified differences.

methodsTranscriptomic profiles were generated by microarray analysis of blood from 610 patients with asthma and control participants in the U-BIOPRED (Unbiased Biomarkers in Prediction of Respiratory Disease Outcomes) study. Differentially expressed genes (DEGs) were identified by analysis of variance, including covariates for RNA quality, sex, and clinical site, and Ingenuity Pathway Analysis was applied. Patient subgroups based on DEGs were created by hierarchical clustering and topological data analysis. MEASUREMENTS AND MAIN

resultsA total of 1,693 genes were differentially expressed between patients with severe asthma and participants without asthma. The differences from participants without asthma in the nonsmoking severe asthma and mild/moderate asthma subgroups were significantly related (r = 0.76), with a larger effect size in the severe asthma group. The majority of, but not all, differences were explained by differences in circulating immune cell populations. Pathway analysis showed an increase in chemotaxis, migration, and myeloid cell trafficking in patients with severe asthma, decreased B-lymphocyte development and hematopoietic progenitor cells, and lymphoid organ hypoplasia. Cluster analysis of DEGs led to the creation of subgroups among the patients with severe asthma who differed in molecular responses to oral corticosteroids.

conclusionsBlood gene expression differences between clinically defined subgroups of patients with asthma and individuals without asthma, as well as subgroups of patients with severe asthma defined by transcript profiles, show the value of blood analysis in stratifying patients with asthma and identifying molecular pathways for further study. Clinical trial registered with www.clinicaltrials.gov (NCT01982162).

Indexed as

Adrenal Cortex HormonesAdultAsthmaCluster AnalysisCohort StudiesEuropeFemaleGene Expression ProfilingHumansMaleMicroarray AnalysisMiddle AgedProspective StudiesSeverity of Illness IndexTranscriptomeAdrenal Cortex Hormonesbiomarkerimmune cellmicroarray

Identifiers

PMID27925796
OpenAlexW2565713774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.